Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC
Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC
Active, not recruiting · NCT03970746 · Registry updated 2025-05-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2025-05-29 | NCT03970746 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| PDC*line Pharma SAS | 1 |
16 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Antoni Van Leeuwenhoek (Nederlands Kanker Instituut) | Amsterdam | Netherlands | 1 |
| AZ Delta vzw | Roeselare | Belgium | 14 |
| AZ Groeninge | Kortrijk | Belgium | 53 |
| AZ Sint-Nikolaas | Sint-Niklaas | Belgium | 1 |
| Centre Léon Bérard, Centre de lutte contre le cancer | Lyon | France | 1 |
| CHU Grenoble | Grenoble | France | 19 |
| CHU Liège- Sart Tilman | Liège | Belgium | 1 |
| Chu Nantes | Nantes | France | 45 |
| Grand Hôpital de Charleroi | Charleroi | Belgium | 5 |
| Jeroen Bosch Ziekenhuis - 's hertogenbosch | 's-Hertogenbosch | Netherlands | 1 |
| Jessa Ziekenhuis | Hasselt | Belgium | 38 |
| Kliniken der Stadt Köln GmbH | Cologne | Germany | 1 |
| Leiden University Medical Center (LUMC) | Leiden | Netherlands | 4 |
| University Clinical Centre | Gdansk | Poland | 1 |
| University Hospitals KU Leuven | Leuven | Belgium | 1 |
| Universitätsklinikum Franlkfurt | Frankfurt am Main | Germany | 1 |